Posts by: Carolina Henriques

Carolina Henriques

Carolina holds a BSc in Anthropology and a MSc in Urban Studies., and brings her interdisciplinary skills to her writing on a range of different topics in science, research and advocacy news.

March 29, 2016May 13, 2016

Cystic Fibrosis Patients May Have Better Treatment Options with Personalized Medicine

Cystic Fibrosis, News

Personalized medicine may offer better treatment options for highly variable diseases such as cystic fibrosis (CF), where treatments are based on individual factors right down to the molecular level. This is particularly ... Read more

March 29, 2016May 13, 2016

Digital Aid to Manage COPD and Asthma Being Made Available to RESPIMAT Inhaler Users

Asthma, COPD, News

Propeller Health and Boehringer Ingelheim Pharmaceuticals recently announced a commercial collaboration, based on joint use of the companies’ health tools and services, in an effort to help people better manage long-term lung conditions like asthma and ... Read more

March 28, 2016April 4, 2016

Drug Company Collaboration for IPF Therapy Leads to Positive Results; Phase 1 Trial to Launch in 2017

Idiopathic Pulmonary Fibrosis, News

Synairgen recently announced positive results from its collaboration with Pharmaxis in their goal to develop a lysyl oxidase type 2 enzyme (LOXL2) inhibitor as an innovative treatment for the life-threatening lung disease ... Read more

March 23, 2016March 23, 2016

Trinnovate Invests Heavily in VisionGate’s Lung Cancer Clinical Trials

Lung Cancer, News

Trinnovate Ventures recently announced it is partnering with VisionGate, a Phoenix-based company dedicated to improving diagnosis and treatment for lung cancer, to support the clinical trial programs for VisionGate’s LuCED (a ... Read more

March 23, 2016May 13, 2016

Laurent Pharma to Prepare Phase 2 Trial for Cystic Fibrosis on Heels of New Financing Round

Cystic Fibrosis, News

Montreal-based Laurent Pharmaceuticals recently announced the closing of a financing round, led by new investor Cystic Fibrosis Canada. The round included existing investors such as Aligo Innovation LP and Anges Quebec, and ... Read more

March 22, 2016May 13, 2016

FDA Designation to Speed Testing of Inhaled Antibiotic, Levofloxacin, to Treat Lung Infections

Bronchiectasis, Cystic Fibrosis, News

Raptor Pharmaceutical Corp. announced that its proprietary inhaled levofloxacin, MP-376, has been given Qualified Infectious Disease Product (QIDP) designation by the U.S. Food and Drug Administration (FDA) to treat three specific indications: ... Read more

March 21, 2016May 13, 2016

Lung Infections in Cystic Fibrosis Found From Airborne Bacteria Triggering Fungal Growth

Cystic Fibrosis, News

According to new research, volatile compounds released by a bacterial pathogen called Pseudomonas aeruginosa can trigger the growth of a fungal pathogen often found in cystic fibrosis (CF) patients. This is ... Read more

March 16, 2016May 13, 2016

Large-scale NAVIGATE Lung Cancer Trial Enrolls First Patients in Europe, Medtronic Announces

Lung Cancer, News

Medtronic recently announced it has enrolled its first European patients in its NAVIGATE clinical trial. The international trial will enroll a total of 2,500 patients to assessment the long-term outcomes of the company’s superDimension ... Read more

March 15, 2016May 13, 2016

New Gene Study to Determine Why Some People Are More Prone to Developing Asthma

Asthma, News

New research from the University of Southampton in England is set to expand scientists’ knowledge about why some people are more prone to develop asthma by analyzing a gene called ADAM33 – typically ... Read more

March 14, 2016May 13, 2016

Nit1 Gene May Contribute to Lung Cancer Development, Study Suggests

Lung Cancer, News

Recent research suggested that a “conserved” gene called Nitrilase 1 (Nit1) might contribute to lung cancer development. The findings were published in the journal Oncotarget under the title “Nitrilase 1 modulates ... Read more